1. Home
  2. PNFP vs CYTK Comparison

PNFP vs CYTK Comparison

Compare PNFP & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pinnacle Financial Partners Inc.

PNFP

Pinnacle Financial Partners Inc.

HOLD

Current Price

$97.52

Market Cap

7.8B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$64.27

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNFP
CYTK
Founded
2000
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
PNFP
CYTK
Price
$97.52
$64.27
Analyst Decision
Buy
Strong Buy
Analyst Count
16
16
Target Price
$112.00
$82.38
AVG Volume (30 Days)
1.5M
2.1M
Earning Date
01-21-2026
02-26-2026
Dividend Yield
0.99%
N/A
EPS Growth
49.26
N/A
EPS
7.83
N/A
Revenue
$1,885,186,000.00
$87,211,000.00
Revenue This Year
$31.73
$346.43
Revenue Next Year
$128.60
$57.69
P/E Ratio
$12.39
N/A
Revenue Growth
21.58
2609.26
52 Week Low
$81.57
$29.31
52 Week High
$127.85
$70.98

Technical Indicators

Market Signals
Indicator
PNFP
CYTK
Relative Strength Index (RSI) 53.08 54.42
Support Level $92.16 $58.85
Resistance Level $100.50 $64.43
Average True Range (ATR) 2.54 2.86
MACD -0.80 0.02
Stochastic Oscillator 56.08 48.80

Price Performance

Historical Comparison
PNFP
CYTK

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: